Kartik Konduri

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

Mark A. Socinski, Egbert F. Smit, Paul Lorigan et al. · Journal of Clinical Oncology · 2009 · 215 citations · Full text

Medicine, Oncology, Pharmacology +12

<i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer

Kartik Konduri, Jean‐Nicolas Gallant, Young Kwang Chae et al. · Cancer Discovery · 2016 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib

Sara D. Robinson, Joyce O’Shaughnessy, C. Lance Cowey et al. · Lung Cancer · 2014 · 92 citations

Medicine, Oncology, Pharmacology +12

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)

David R. Spigel, Robert M. Jotte, John Nemunaitis et al. · Journal of Thoracic Oncology · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacology +14